Global NGS Kits Market Report 2022 to 2032: Growing Application of NGS Kits in Precision Medicine and Molecular Diagnostics Presents Opportunities

Global NGS Kit Market

Dublin, 01 Dec. 2022 (GLOBE NEWSWIRE) — The “NGS Kits Market – A Global and Regional Analysis: Focus on Workflow, Sequencing Type, Usage, Application, End User and Region – Analysis and forecast, 2022-2032” report has been added to from ResearchAndMarkets.com offer.

In 2021, the Global NGS Kits Market was valued at USD 4,553.6 Million, and it is projected to reach USD 26,057.4 Million by 2032, growing at a CAGR of 17.27% during the forecast period. forecast 2022-2032.

The growth of the global NGS kits market is expected to be driven by advances in sequencing technology benefiting treatment and diagnosis, coupled with the presence of a regulatory framework relating to sequencing and governments investing in large clinical and diagnostic laboratories to enable reliable NGS testing for a variety of chronic and infectious diseases.

Market life cycle stage

The global market for NGS kits is growing. Next-generation sequencing (NGS) has recently grown in popularity and has become a crucial diagnostic tool for many diseases. The NGS kit market is a disruptive technical advancement in the life science industry that has paved the way for the creation of various revolutionary medicinal techniques aimed at solving the major global health problem.

Impact

• The presence of NGS Kits NGS Kit suppliers in regions such as North America and Europe is having a major impact on the market. For example, Illumina, Inc. is a world leader in providing technologically advanced genomic and genetic sequencing and analysis solutions to government laboratories, academic and research institutions, hospitals, pharmaceuticals, laboratories molecular diagnostics, biotechnology and consumers. genomics companies. The company also provides sequencing solutions in the field of cancer research.

Impact of COVID-19

The COVID-19 pandemic has resulted in showing a positive impact on the overall market, owing to its increased adoption for the diagnosis of respiratory virus i.e. coronavirus. NGS is a useful technology for characterizing and finding viruses in the environment, animals and people during viral pandemics.

The story continues

Additionally, NGS can offer useful information to researchers and healthcare professionals trying to create the best possible treatment alternatives. The steps performed in the COVID-19 testing process include extracting a sample of RNA from patients, which is then transcribed into cDNA and then amplified by PCR. Before the PCR step, however, a sample library must be prepared, which is the most time-consuming step in the whole process. So, with the help of NGS kits, this protocol can be performed quickly. Therefore, with the emergence of COVID-19, the popularity of NGS kits has increased.

Recent Developments in the Global NGS Kits Market

• In June 2022, PerkinElmer Inc. introduced the library prep kits, namely NEXTFLEX Small RNA-Seq v4 Kit, NEXTFLEX Rapid XP V2 DNA-Seq Kit and PG-Seq Rapid v2 Kit.

• In June 2022, Beckman Coulter, Inc. partnered with Integrated DNA Technologies to distribute the Biomek NGenius Next Generation Sequencing Library Preparation System. This system is a versatile liquid handler for the preparation of NGS libraries. The Biomek NGenius system is equipped with an FFPE DNA library preparation kit and Integrated DNA Technologies’ cfDNA xGen, which can help researchers optimize library generation from low input degraded samples such as FFPE samples.

• In March 2022, Illumina, Inc. launched the TruSight Oncology (TSO) Comprehensive (EU), a unique test that detects multiple tumor genes and biomarkers to reveal a patient’s cancer-specific molecular profile. With its global launch in Europe, the IVD kit is being manufactured to inform precision medicine decisions for cancer patients across the continent.

• In February 2020, Thermo Fisher Scientific introduced a new NGS-based solution that enables reproductive health researchers to analyze a wide range of key genetic markers. The Ion Torrent CarrierSeq ECS Kit for the Ion GeneStudio S5 System has consolidated a cross-platform approach to expanded carrier screening (ECS) into a single solution that expands the company’s reproductive health research portfolio.

Demand – Factors and Limitations

Following are the demand drivers for the global NGS kit market:

• Increased incidence of infectious diseases and genetic disorders

• Exponential increase in demand for next-generation sequencing (NGS) due to reduction in cost of genome sequencing

• Growing funding for genome science research

The market is also expected to face some limitations owing to the following challenges:

Key Market Players and Competition Summary

The profiled companies have been selected based on input collected from primary experts and analysis of company coverage, product portfolio and market penetration. The major players in the upper segment include NGS kit manufacturers that offer major products under workflows such as library preparation, cluster generation, and sequencing in the market.

Some of the most prominent established names in this market are:

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc.

• BGI Group

• Biogenic Creator.

• Danaher.

• F. Hoffmann-La Roche SA

• Hologic, Inc.

• Illumina, Inc.

• New England Biolabs

• Oxford Nanopore Technologies plc.

• Pacific Biosciences of California, Inc.

• Perkin Elmer Inc.

• Promega Corporation

• QIAGEN AG

• seqWell

• Takara Bio Inc.

• Tecan Trading AG

• ThermoFisher Scientific, Inc.

• Twist Bioscience Corporation

Main topics covered:

1 Market Overview

2 Industry overview
2.1 Industry Overview
2.1.1 Legal requirements and framework in the United States
2.1.2 Guidance published by the US FDA:
2.1.3 US FDA regulations
2.1.4 Legal requirements and framework in Europe
2.1.5 Legal requirements and framework in Asia-Pacific
2.1.5.1 China
2.1.5.2 Japan
2.1.5.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
2.1.5.2.2 Ministry of Health, Labor and Welfare (MHLW)
2.1.5.3 India
2.2 Industry trends
2.3 Patent Analysis
2.3.1 Trend in patent filings
2.3.2 Patent Analysis (by Year)
2.3.3 Patent Analysis (by Region)
2.3.4 Patent Analysis (by Country)

3 Market dynamics
3.1 Overview
3.1.1 Market Drivers
3.1.1.1 Increased Incidence of Infectious Diseases and Genetic Disorders
3.1.1.2 Exponential Increase in Demand for Next Generation Sequencing (NGS) Due to Reduction in Cost of Genome Sequencing
3.1.1.3 Increased Funding for Genome Science Research
3.1.2 Market challenges
3.1.2.1 Shortage of skilled professionals and lack of infrastructure in emerging economies
3.1.2.2 Strict regulatory standards related to NGS
3.1.3 Market opportunities
3.1.3.1 Direct-to-consumer service on the rise
3.1.3.2 Increasing Application of NGS Kits in Precision Medicine and Molecular Diagnostics
3.1.3.3 Increase in business and corporate strategy expected to further strengthen the NGS Kit market
3.1.4 Impact of COVID-19 on the Global NGS Kits Market
3.1.4.1 Effect of COVID-19 on R&D and workforce

4 Competitive landscape
4.1 Overview
4.1.1 Synergistic Activities
4.1.2 Product launch and product approval
4.1.3 Mergers and Acquisitions
4.1.4 Fundraising and other activities
4.1.5 Market Share Analysis, 2020-2021
4.1.6 Growth Share Analysis
4.1.6.1 Growth Share Analysis (by Use)
4.1.6.2 Growth Share Analysis (by Application)
4.2 Supply Chain Analysis
4.2.1 Key Supply Chain Entities

5 Global NGS Kits Market, by Workflow, by Value (USD Million), 2021-2032
5.1 Overview
5.2 Preparation of the library
5.2.1 Library preparation kits
5.2.2 Target enrichment kits
5.3 Generation of clusters
5.4 Sequencing reagents/kits
5.4.1 DNA sequencing kits
5.4.2 RNA sequencing kits

6 Global NGS Kits Market, by Sequencing Type, by Value (Million USD), 2021-2032
6.1 Overview
6.2 WES and WGS
6.3 Targeted sequencing
6.4 Long read sequencing
6.5 Other sequencing

7 Global NGS Kits Market, By Area of ​​Use, by Value (USD Million), 2021-2032
7.1 Overview
7.2 Clinic
7.3 Search

8 Global NGS Kits Market, by Application, by Value (USD Million), 2021-2032
8.1 Overview
8.2 Oncology
8.3 Rare diseases
8.4 Genetic disorders
8.5 Reproductive Health
8.6 Others

9 Global NGS Kits Market, By End User, By Value (USD Million), 2021-2032
9.1 Overview
9.2 Academic and research institutions
9.3 Pharmaceutical and biotechnology companies
9.4 Clinical and diagnostic laboratories
9.5 Others

10 Global NGS Kits Market, by Region, USD Million, 2021-2032

11 Market – Competitive Benchmarking and Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/hu0jjs

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900